NUH 0.00% 8.1¢ nuheara limited

Ann: Suspension from Quotation, page-203

  1. 287 Posts.
    lightbulb Created with Sketch. 157

    I agree, but the reason they are not on both marketplaces, is that they have not (yet) produced a product that can sell in enough volume in the CE retail store segment, at the correct price point ( CIRCA 199 USD) to hold the shelf space down. On the hearing side, all that had to be done was do one solid deal with one of the big five, and they were away. As an example, Amplifon has over 9200 stores in 25 different countries, you have an entry level hearing product that is prime for people with mild hearing loss, it does not have to be called a "hearing aid" to be sold in those stores as its an entry level aid for mild hearing loss that is in fact a lead generator for those stores as a future big money hearing aid customer that they capture at point of entry to hearing loss.

    People dont know they have mild hearing loss until they go and get tested. Where then do you sell the product? At 9200 Amplifon stores worldwide, with assisted help from an audiologist, who has nothing to sell you for mild hearing loss and generates a sale where none currently exist, or in Walmart, in a glass box, with no help, and no one to tell you that this product will work for you. It is not rocket science to work it out.
 
watchlist Created with Sketch. Add NUH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.